Learn More
We propose a new model of two-sided matching markets, which allows for complex heterogeneous preferences, but is more tractable than the standard model, yielding rich comparative statics and new results on large matching markets. We simplify the standard Gale and Shapley (1962) model in two ways. First, following Aumann (1964) we consider a setting where a(More)
The Boston mechanism is among the most popular school choice procedures in use. Yet, the mechanism has been criticized for its poor incentive and welfare performances, which led the Boston Public Schools to recently replace it with Gale and Shapley's deferred acceptance algorithm (henceforth, DA). The DA elicits truthful revelation of " ordinal "(More)
BACKGROUND C-reactive protein (CRP) was an independent prognostic factor for metastatic renal cell carcinoma in the cytokine era. However, the impact of CRP on the survival of metastatic renal cell carcinoma patients treated with tyrosine kinase inhibitors has not yet been investigated. Therefore, we further evaluated the prognostic impact of CRP for(More)
We synthesized a galactose derivative, N-octyl-4-epi-beta-valienamine (NOEV), for a molecular therapy (chemical chaperone therapy) of a human neurogenetic disease, beta-galactosidosis (GM1-gangliosidosis and Morquio B disease). It is a potent inhibitor of lysosomal beta-galactosidase in vitro. Addition of NOEV in the culture medium restored mutant enzyme(More)
OBJECTIVE To verify the prognostic impact of C-reactive protein (CRP) for patients with castration-resistant prostate cancer (CRPC) treated with docetaxel in a single institution. METHODS A group of 80 consecutive patients with CRPC were treated with docetaxel in our institution from January 2005 to May 2010. The patients received 75 mg/m(2) of docetaxel(More)
CD22/Siglec-2, an important inhibitory co-receptor on B-lymphocytes, is known to recognize alpha2-6-sialylated glycan as a specific ligand. Here we propose that the alpha2-6-sialylated and 6-GlcNAc-sulfated determinant serves as a preferred ligand for CD22 because the binding of a human B-cell line to CD22 was almost completely abrogated after incubating(More)
In an attempt to increase the placement of medical residents to rural hospitals , the Japanese government recently introduced " regional caps " which restrict the total number of residents matched within each region of the country. The government modified the deferred acceptance mechanism incorporating the regional caps. This paper shows that the current(More)
This paper considers the matching problem with regional quotas, in particular, regional minimum quotas. Although such quotas are relevant in many real-world settings, there is a lack of strategy-proof mechanisms that consider regional minimum quotas. We first show that without any restrictions on the region structure, finding a feasible matching that(More)